Jonathan P Singer

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Quality of life in lung transplantation
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and Cardiovascular Research Institute, UC San Francisco, San Francisco, California 94117, USA
    Semin Respir Crit Care Med 34:421-30. 2013
  2. doi request reprint A familial history of pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis
    Tsukasa Okamoto
    Department of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan
    Respiration 85:384-90. 2013
  3. doi request reprint Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, CA 94143 0111, USA
    Respiration 85:375-83. 2013
  4. doi request reprint Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94117, USA
    Med Clin North Am 96:767-87. 2012
  5. pmc Survival following lung transplantation for silicosis and other occupational lung diseases
    J P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA
    Occup Med (Lond) 62:134-7. 2012
  6. pmc The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans
    Jonathan P Singer
    Division of Pulmonary Critical Care Medicine, UC San Francisco, CA 94143, USA
    J Intensive Care Med 25:233-9. 2010
  7. pmc Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function
    Jonathan Singer
    Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California 94143, USA
    J Cardiopulm Rehabil Prev 31:111-9. 2011
  8. pmc Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Heart Lung Transplant 29:1009-13. 2010
  9. doi request reprint The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation
    J P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, USA
    Am J Transplant 11:2197-204. 2011
  10. pmc The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients
    Christopher Metchnikoff
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94115, USA
    J Am Acad Dermatol 67:829-35. 2012

Collaborators

Detail Information

Publications16

  1. doi request reprint Quality of life in lung transplantation
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and Cardiovascular Research Institute, UC San Francisco, San Francisco, California 94117, USA
    Semin Respir Crit Care Med 34:421-30. 2013
    ..More research is needed, particularly longitudinal, multicenter studies, to better understand the trajectory and determinants of HRQL after lung transplantation, and the impact of targeted interventions to improve HRQL...
  2. doi request reprint A familial history of pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis
    Tsukasa Okamoto
    Department of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan
    Respiration 85:384-90. 2013
    ..Patients with chronic HP often have a family history of pulmonary fibrosis. This strongly suggests that both genetic and environmental factors play an important role in the pathogenesis of chronic HP...
  3. doi request reprint Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, CA 94143 0111, USA
    Respiration 85:375-83. 2013
    ..Although chronic obstructive pulmonary disease (COPD) is a major cause of disability worldwide, its determinants remain poorly defined...
  4. doi request reprint Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience
    Jonathan P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94117, USA
    Med Clin North Am 96:767-87. 2012
    ..Future research will provide a better understanding of the effects of COPD on HRQOL and the impact of various interventions...
  5. pmc Survival following lung transplantation for silicosis and other occupational lung diseases
    J P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA
    Occup Med (Lond) 62:134-7. 2012
    ..Information is scant assessing outcomes in lung transplantation (LT) in advanced occupational lung diseases (OLD)...
  6. pmc The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans
    Jonathan P Singer
    Division of Pulmonary Critical Care Medicine, UC San Francisco, CA 94143, USA
    J Intensive Care Med 25:233-9. 2010
    ....
  7. pmc Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function
    Jonathan Singer
    Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California 94143, USA
    J Cardiopulm Rehabil Prev 31:111-9. 2011
    ..We sought to quantify the impact of respiratory muscle and lower extremity strength on exercise capacity and lower extremity function (LEF) in patients with chronic obstructive pulmonary disease (COPD)...
  8. pmc Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Heart Lung Transplant 29:1009-13. 2010
    ..Having identified a high incidence of supratherapeutic anti-factor Xa levels in lung transplant recipients, we aimed to elucidate the relationship between enoxaparin dose and anti-factor Xa level in this patient population...
  9. doi request reprint The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation
    J P Singer
    Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, USA
    Am J Transplant 11:2197-204. 2011
    ..Notably, the increased risk of death appears to be strongest the early posttransplant period and limited to certain pretransplant diagnoses...
  10. pmc The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients
    Christopher Metchnikoff
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94115, USA
    J Am Acad Dermatol 67:829-35. 2012
    ..The newly updated 7th edition American Joint Committee on Cancer (AJCC) staging system for cSCC is based on consensus expert opinion and requires validation in large cohort studies and in specific patient subpopulations...
  11. pmc Outcomes in systemic sclerosis-related lung disease after lung transplantation
    Peter D Sottile
    Department of Internal Medicine, University of California San Francisco, San Francisco, CA, USA
    Transplantation 95:975-80. 2013
    ..We sought to evaluate posttransplantation outcomes in persons with SSc-LD with esophageal involvement compared with persons with nonconnective tissue disease-related interstitial lung disease (nCTD-ILD)...
  12. pmc Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD
    Moshe Zutler
    Department of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, California 94143, USA
    Prim Care Respir J 21:194-201. 2012
    ..Obesity contributes to respiratory symptoms and exercise limitation, but the relationships between obesity, airflow obstruction (AO), respiratory symptoms and functional limitation are complex...
  13. pmc Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection
    David M Sayah
    Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Clin Transplant 27:E64-71. 2013
    ..Community acquired respiratory virus (CARV) infections in lung transplant recipients (LTR) have been associated with adverse outcomes, including acute rejection (AR) and decline in allograft function, in some but not in all studies...
  14. doi request reprint Use of sublingual tacrolimus in lung transplant recipients
    Katherine D Watkins
    Department of Clinical Pharmacy, University of California, San Francisco, California 94143 0622, USA
    J Heart Lung Transplant 31:127-32. 2012
    ..We aimed to identify a dose conversion ratio between oral and sublingual tacrolimus in LTRs...
  15. pmc High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients
    Jonathan P Singer
    Division of Pulmonary and Critical Care Medicine, University of California at San Francisco, San Francisco, California 94115, USA
    J Heart Lung Transplant 31:694-9. 2012
    ..Voriconazole, which is associated with phototoxic side effects in some patients, may be an additional risk factor for SCC in this population...
  16. doi request reprint An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients
    Leah Smith
    Department of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco, CA 94143 0903, USA
    Transpl Int 25:172-8. 2012
    ..30). The involvement of trainees, pre-transplant diagnosis, and transplant type do not significantly impact the rate of bronchoscopic complications in lung transplant recipients...